Biodesix (NASDAQ:BDSX) Given New $2.50 Price Target at Canaccord Genuity Group
Biodesix (NASDAQ:BDSX – Get Free Report) had its price target cut by Canaccord Genuity Group from $3.50 to $2.50 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside of 367.81% from the stock’s […]
Biodesix (NASDAQ:BDSX – Get Free Report) had its price target cut by Canaccord Genuity Group from $3.50 to $2.50 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside of 367.81% from the stock’s […]
